Back to search
Dementia Alzheimer Type
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia Alzheimer Type trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia Alzheimer Type trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of this study is to evaluate the efficacy of DMTS on frequency and severity of agitation associated with dementia of the Alzheimer's type,…
An open-label, exploratory, phase II, proof-of concept, clinical study to assess the safety and tolerability of EI-1071 and the effects of EI-1071 on neuroinfla…
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutatio…
The goal of this placebo-controlled double-blind Phase 2 clinical trial is to test in people with early Alzheimer's Disease. The main questions it aims to answ…
This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheime…
Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably.
The primary objective of this open-label extension trial was to evaluate the long-term safety of AXS-05 for the treatment of Alzheimer's disease agitation in su…
Immediate family members shoulder the majority of care responsibilities for persons living with dementia. However, due to various societal changes, elder care r…